Company: ARTL
Filing Date: 2025-09-05
Form Type: 424B5
Source: 0001640334-25-001629
Chunk: 19

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-09-05
Form: 424B5
Chunk 19
---
-term corporate debt obligations and SEC-registered money market accounts.

| S-11 |

<div align='center'>CAPITALIZATION</div>

The table below sets forth our capitalization and indebtedness as of June 30, 2025:

| ● | on an actual basis; and |

| ● | on an as adjusted basis to give further effect to this offering based on a public offering price of $4.40 per share of common stock and a public offering price of $4.399 per Pre-funded Warrant, after deducting the underwriting discounts, and estimated offering expenses payable by us. |

You should read this table together with our consolidated financial statements and notes included in the information incorporated by reference into this prospectus supplement and the accompanying prospectus.

|                                                                                                                             |     | As of June 30, 2025  |         |   |     |                         |         |   |
|:----------------------------------------------------------------------------------------------------------------------------|:----|:---------------------|--------:|:--|:----|:------------------------|--------:|:--|
|                                                                                                                             |     | Actual  (Unaudited)  |         |   |     | As Adjusted (Unaudited) |         |   |
|                                                                                                                             |     | -U.S. $ in thousands |         |   |     |                         |         |   |
| Cash and cash equivalents                                                                                                   |     | $                    |   2,066 |   |     | $                       |   4,656 |   |
| Total current liabilities                                                                                                   |     | $                    |   5,712 |   |     | $                       |   5,712 |   |
| Stockholders’ equity                                                                                                        |     |                      |         |   |     |                         |         |   |
| Preferred Stock, par value $0.001, 69,445 shares authorized, 0 shares issued and outstanding as of June 30, 2025            |     |                      |       - |   |     |                         |       - |   |
| Common Stock, par value $0.001, 500,000,000 shares authorized and 704,425 shares issued and outstanding as of June 30, 2025 |     |                      |       1 |   |     |                         |       1 |   |
| Additional paid in capital                                                                                                  |     |                      |  54,617 |   |     |                         |  57,436 |   |
| Accumulated